ALC
Alcon Inc. Ordinary Shares
$73.64
장중 · Vol 14.2K · 52주 $61.84–$87.64 · 기준 2026. 8. 21. PM 3:59 ET
일봉 $71.90 · Aug 31, 2026
ALC 가격 추세
종가
$71.90
시가
$71.69
고가
$71.90
저가
$71.87
30초 브리핑
ALC 오늘의 판단 요약
보유 데이터를 비교 가능한 문장으로 해석한 요약입니다.
52주 범위의 46%
52주 범위 중간 구간으로 가격 위치만으로 방향성은 제한적입니다.
Forward P/E 18.1배
선행 P/E가 낮아 시장은 이익 증가를 반영하고 있습니다.
20일 평균의 0.8배
거래량은 최근 평균 범위입니다.
2026-11-10
실적 전후 변동성 확대 가능성이 있으므로 컨센서스 범위와 옵션 기대변동을 함께 보세요.
펀더멘털 기준 Sep 1, 2026 · 규칙 기반 요약이며 투자 조언이 아닙니다.
핵심 통계
ALC 일봉·펀더멘털 스냅샷 기준 주요 지표
펀더멘털 스냅샷 Sep 1, 2026
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Chemin de Blandonnet 8 · Geneva, Switzerland · 직원 25,000명
시가총액
$34.83B
Trailing P/E
55.0
최근 12개월 이익 기준
Forward P/E
18.1
이익 증가 기대 반영
EPS (TTM)
$1.31
배당 수익률
0.50%
배당성향
27.0%
베타
0.69
시장보다 방어적
ROE
2.9%
P/B
1.61
EV/EBITDA
16.1
52주 범위
$61.84 – $87.64
현재 위치 46%
거래량
994.2K
20일 평균 1.22M · 0.8배
애널리스트 의견
매수 77%
총 26명 · 0m
DITM LEAPS Analysis
ALC 장기 DITM 콜옵션을 진입 적합도 순으로 비교
| Contract | Expiry | Strike | Price | Lev. | Delta | Extrinsic | Spread | IV | OI | Score | 상세 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALC280121C00045000 | 1/21/28 · 1.4Y | $45.00 | $31.85 | 2.0x | 0.8754 | 15.0% | 4.08% | 54.39% | 16 | 77.59 | |
| ALC280121C00047500 | 1/21/28 · 1.4Y | $47.50 | $29.80 | 2.1x | 0.8612 | 17.6% | 4.70% | 52.31% | 28 | 75.75 | |
| ALC280121C00050000 | 1/21/28 · 1.4Y | $50.00 | $27.60 | 2.2x | 0.8422 | 20.1% | 4.35% | 52.17% | 47 | 73.45 | |
| ALC280121C00055000 | 1/21/28 · 1.4Y | $55.00 | $21.75 | 2.7x | 0.8097 | 21.6% | 20.69% | 47.11% | 2 | 62.92 | |
| ALC271217C00060000 | 12/17/27 · 1.3Y | $60.00 | $18.25 | 3.1x | 0.7771 | 33.9% | 4.93% | 39.42% | 2 | 60.43 | |
| ALC280121C00057500 | 1/21/28 · 1.4Y | $57.50 | $21.75 | 2.6x | 0.7888 | 33.1% | 5.06% | 46.05% | 1 | 59.55 | |
| ALC280121C00060000 | 1/21/28 · 1.4Y | $60.00 | $19.15 | 2.9x | 0.7691 | 37.0% | 10.97% | 43.40% | 101 | 59.47 | |
| ALC271217C00062500 | 12/17/27 · 1.3Y | $62.50 | $16.50 | 3.3x | 0.7519 | 42.1% | 4.85% | 37.95% | 45 | 57.90 |
재무제표
ALC 연간 손익·현금흐름·재무상태
매출 성장률
+4.9%
최근 연간 YoY
EPS 성장률
-3.4%
최근 연간 YoY
영업이익률
13.1%
최근 연간
FCF 마진
15.5%
잉여현금흐름 / 매출
매출 추세
순이익 추세
잉여현금흐름 추세
| 항목 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| 매출 | $10.40B+4.9% | $9.91B+4.8% | $9.46B+8.5% | $8.72B |
| 매출총이익 | $5.75B+4.2% | $5.51B+5.1% | $5.25B+10.5% | $4.75B |
| 영업이익 | $1.36B-3.8% | $1.41B+36.0% | $1.04B+54.6% | $672.00M |
| 순이익 | $980.00M-3.7% | $1.02B+4.5% | $974.00M+190.7% | $335.00M |
| 희석 EPS | $1.98-3.4% | $2.05+4.6% | $1.96+188.2% | $0.68 |
| EBITDA | $2.70B+0.9% | $2.68B+19.4% | $2.24B+30.3% | $1.72B |
| 영업현금흐름 | $2.27B+9.3% | $2.08B+49.6% | $1.39B+14.1% | $1.22B |
| 잉여현금흐름 | $1.61B+14.3% | $1.41B+162.0% | $537.00M+13.8% | $472.00M |
| 총자산 | $31.55B+4.0% | $30.35B+2.5% | $29.61B+1.5% | $29.16B |
| 총부채 | $509.00M+2.4% | $497.00M-90.3% | $5.13B+1.3% | $5.07B |
최신 연도 우선 · 작은 퍼센트는 직전 연도 대비 변화입니다.
캘린더
ALC 실적·배당 일정
매출 하단
$2.73B
EPS 하단
$0.66
매출 상단
$2.82B
배당 지급일
2026-05-07
117일 전
실적 발표일
2026-11-10
D-70
EPS 상단
$0.79
매출 컨센서스
$2.77B
EPS 컨센서스
$0.76
배당락일
2026-05-06
118일 전
최근 배당
| 배당락일 | 주당 배당 |
|---|---|
| May 5, 2026 | $0.3580 |
| May 13, 2025 | $0.3310 |
| May 14, 2024 | $0.2640 |
| May 10, 2023 | $0.2360 |
| May 3, 2022 | $0.2050 |
| May 4, 2021 | $0.1100 |
뉴스
ALC 관련 최신 기사
일반Trump's Pharma Pricing Deal Expands as Healthcare Stocks Keep Climbing
Trump expanded his drug pricing deal to 26 pharma firms as UBS says healthcare stocks still have room to climb.
BeInCrypto · Sep 1, 2026
제품·기술$19.6B Infusion In US Plants With Lower Drug Prices: White House’s Deal With Mid-size Drugmakers
Under the deals, the drug makers would charge Americans no more than the lowest price paid in other rich countries.
Stocktwits · Aug 31, 2026
제품·기술Trump Strikes Medicaid Drug Price Deals With Nine Pharma Firms
The Trump administration has struck new drug pricing agreements with nine biotech and pharmaceutical companies including UCB SA, Bridgebio Pharma Inc. and Sun Pharmaceutical Industries Ltd.
Bloomberg · Aug 31, 2026
제품·기술SGA Exits Alcon (ALC) as Cataract Demand Slows and Competition Rises
Sustainable Growth Advisers (SGA), an investment management company, released its second-quarter 2026 investor letter for its “Global Growth Strategy.” The letter can be downloaded here. The SGA Global Growth Portfolio returned 7.4% gross and 7.2% net, compared with 14.9% for the MSCI ACWI and 19.8% for the MSCI ACWI Growth Index. Momentum leadership and enthusiasm around […]
Insider Monkey · Aug 24, 2026
제품·기술GKOS Stock Surges 67% Year to Date: What's Driving the Rally?
Glaukos' iDose TR momentum and Epioxa launch are driving record growth, higher 2026 guidance and a broader ophthalmology platform.
Zacks · Aug 20, 2026
- 일반
What Makes Alcon (ALC) a Bullish Bet?
Pershing Square Holdings, an investment holding company, released its second quarter 2026 investor letter. A copy of the letter can be downloaded here. Pershing Square is an alternative asset manager that primarily manages capital in publicly traded investment vehicles, with 98% of its capital structure dedicated to such assets, including Howard Hughes Holdings. This capital […]
Insider Monkey · Aug 19, 2026
제품·기술COO Stock Surges 22% in Past Three Months: What's Driving the Uptrend?
Cooper Companies' 22% three-month surge reflects contact lens share gains, MiSight growth and a recovering fertility business.
Zacks · Aug 18, 2026
제품·기술Bill Ackman Bets Big on Visa After It Lagged the Market for 5 Years. Should You?
Bill Ackman just made Visa a major new bet after the stock trailed the S&P 500 for five straight years. Whether that lag signals a coiled spring or a structural problem depends on threats most investors are not watching closely enough.
24/7 Wall St. · Aug 18, 2026
실적Alcon (ALC) Q2 2026 Earnings Call Transcript
Net sales grew 7% to $2.8 billion as surgical and vision care divisions both expanded.
Motley Fool · Aug 17, 2026
일반Bill Ackman lost $400M dumping Netflix — now says it ‘won the streaming wars.’ Should you rebuy a stock that burned you?
Here's what changed.
Moneywise · Aug 17, 2026
홀더
ALC 내부자·기관 보유 현황
최신 보고 목록 기준이며 실제 거래 시점과 보고일 사이에는 시차가 있습니다.
기관 보유
66.1%
기관 보유 (유동주식)
66.2%
내부자 보유
0.2%
기관 수
1,181
주요 기관 홀더
| 홀더 | 주식 수 | 평가액 | 지분 | 변동 | 보고일 |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 14.75M | $1.06B | 2.9% | -0.8% | Jun 30, 2026 |
| Bank Of New York Mellon Corporation | 13.06M | $940.96M | 2.6% | -16.7% | Jun 30, 2026 |
| NORGES BANK | 10.98M | $790.98M | 2.2% | -8.9% | Jun 30, 2026 |
| Invesco Ltd. | 10.38M | $748.01M | 2.1% | 27.9% | Jun 30, 2026 |
| Aristotle Capital Management, LLC | 9.98M | $719.09M | 2.0% | -5.7% | Jun 30, 2026 |
| AKO Capital LLP | 9.68M | $697.76M | 1.9% | 3.8% | Jun 30, 2026 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 7.92M | $570.41M | 1.6% | -1.3% | Jun 30, 2026 |
| FMR, LLC | 7.66M | $552.19M | 1.5% | -38.3% | Jun 30, 2026 |
| UBS Group AG | 7.16M | $515.68M | 1.4% | 20.6% | Jun 30, 2026 |
| Amundi | 6.64M | $478.30M | 1.3% | 16.3% | Jun 30, 2026 |
면책조항: 증시가격은 모든 주식 시장의 최신 증시가격을 표시하는 것은 아니며, 정보가 지연되거나 잘못될 수 있습니다. 거래 목적이나 조언이 아닌 정보 제공 목적으로만 제공됩니다.
.png&w=3840&q=75)